Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Fluorouracil × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 84 Stomach Neoplasms 40 Pancreatic Neoplasms 31 Rectal Neoplasms 26 Colonic Neoplasms 25 Neoplasms 21 Esophageal Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 19 Neoplasm Metastasis 17 Cholangiocarcinoma 14 Adenocarcinoma Of Esophagus 14 Carcinoma, Non-Small-Cell Lung 13 Adenocarcinoma 12 Head and Neck Neoplasms 11 Biliary Tract Neoplasms 9 Urinary Bladder Neoplasms 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Ovarian Neoplasms 8 Gastrointestinal Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Keratosis, Actinic 6 Carcinoma, Squamous Cell 6 Advanced Solid Tumors 6 Carcinoma, Hepatocellular 5 Anus Neoplasms 5 Gallbladder Neoplasms 4 Endometrial Neoplasms 4 Carcinoma 4 Breast Neoplasms 4 Appendiceal Neoplasms 4

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡